US Stock MarketDetailed Quotes

SUMITOMO PHARMA CO LTD UNSP ADR EACH REP 1 ORD (SMDPY)

Watchlist
  • 11.750
  • 0.0000.00%
15min DelayClose Apr 7 09:30 ET
4.67BMarket Cap4.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SUMITOMO PHARMA CO LTD UNSP ADR EACH REP 1 ORD (SMDPY) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
Total revenue
120.62B
19.11%108B
26.79%398.83B
19.80%90.68B
-43.38%314.56B
79.53B
-41.56%82.39B
-51.73%76.96B
-52.66%75.69B
-0.80%555.54B
Operating revenue
--120.62B
19.11%108B
26.79%398.83B
19.80%90.68B
-43.38%314.56B
--79.53B
-41.56%82.39B
-51.73%76.96B
-52.66%75.69B
-0.80%555.54B
Cost of revenue
55.44B
26.22%44.11B
21.22%153.44B
14.85%34.95B
-29.25%126.58B
33.39B
-29.96%32.87B
-36.11%29.89B
-33.93%30.43B
13.87%178.92B
Gross profit
65.19B
14.65%63.89B
30.54%245.4B
23.14%55.73B
-50.09%187.98B
46.14B
-47.35%49.52B
-58.21%47.06B
-60.24%45.26B
-6.52%376.63B
Operating expense
52.19B
-27.16%42.85B
-60.27%215.69B
-39.24%58.83B
19.67%542.82B
283.23B
-2.59%80.77B
-47.49%81.99B
-2.40%96.82B
32.37%453.6B
Selling and administrative expenses
--42.94B
-21.39%35.66B
-57.95%180.61B
-39.43%45.36B
15.06%429.54B
--237.98B
-29.48%57.51B
-54.72%59.15B
-3.10%74.89B
49.88%373.32B
-General and administrative expense
--42.94B
-21.39%35.66B
-57.95%180.61B
-39.43%45.36B
15.06%429.54B
--237.98B
-29.48%57.51B
-54.72%59.15B
-3.10%74.89B
49.88%373.32B
Research and development costs
--10.35B
-37.71%8.18B
-55.73%49.87B
-52.87%13.12B
-14.58%112.64B
--38.99B
-10.47%23.29B
-11.92%22.51B
14.01%27.84B
38.94%131.86B
Other operating expenses
--345M
-42.90%366M
-56.07%3.57B
51.54%641M
382.33%8.13B
--6.61B
51.72%663M
20.27%439M
49.47%423M
53.83%1.69B
Operating profit
13B
777.55%21.04B
108.37%29.71B
93.98%-3.11B
-360.95%-354.84B
-237.09B
-380.54%-31.25B
19.75%-34.93B
-452.86%-51.57B
-227.80%-76.98B
Net non-operating interest income expense
-4.88B
-141.70%-8.47B
-135.26%-11.19B
-1.01%20.31B
9.24%31.75B
19.19B
40.57%-17.82B
-45.10%9.86B
-35.88%20.52B
27.86%29.06B
Non-operating interest income
--258M
-97.38%585M
-93.60%2.31B
4.78%22.33B
11.81%36.02B
--20.73B
----
-43.11%10.71B
-35.17%21.32B
24.99%32.22B
Non-operating interest expense
--5.14B
347.06%9.05B
215.64%13.5B
153.13%2.03B
35.39%4.28B
--1.54B
-40.57%17.82B
-1.73%851M
-9.40%800M
3.57%3.16B
Other net income (expense)
Income before tax
8.74B
-30.64%11.93B
105.45%17.61B
155.40%17.2B
-574.28%-323.11B
-217.92B
-160.40%-49.06B
1.96%-25.08B
-166.62%-31.05B
-157.76%-47.92B
Income tax
-80M
-42.70%726M
26.40%-6.02B
-83.78%1.27B
-116.77%-8.19B
-20.69B
161.66%899M
-78.61%3.8B
-57.83%7.81B
15.19%48.79B
Net income
8.82B
-29.68%11.21B
107.50%23.64B
141.01%15.94B
-225.63%-314.93B
-197.23B
-187.41%-49.96B
33.37%-28.87B
-238.34%-38.86B
-338.21%-96.71B
Net income continuous Operations
--8.82B
-29.68%11.21B
107.50%23.64B
141.01%15.94B
-225.63%-314.93B
---197.23B
-187.41%-49.96B
33.37%-28.87B
-238.34%-38.86B
-338.21%-96.71B
Minority interest income
0
0
-97.50%1M
66.67%-1M
100.18%40M
31M
100.06%4M
100.04%2M
99.90%-3M
-40.40%-22.2B
Net income attributable to the parent company
8.82B
-29.69%11.21B
107.50%23.63B
141.01%15.94B
-322.71%-314.97B
-197.26B
-345.38%-49.97B
24.78%-28.88B
-224.92%-38.86B
-232.08%-74.51B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
6M
0
Net income attributable to common stockholders
8.82B
-29.69%11.21B
107.50%23.63B
141.01%15.94B
-322.71%-314.97B
-197.26B
-345.38%-49.97B
24.78%-28.88B
-224.94%-38.87B
-232.08%-74.51B
Basic earnings per share
22.19
-29.67%28.21
107.50%59.49
141.00%40.11
-322.71%-792.79
-496.51
-345.36%-125.77
24.79%-72.68
-224.93%-97.82
-232.09%-187.55
Diluted earnings per share
22.19
-29.67%28.21
107.50%59.49
141.00%40.11
-322.71%-792.79
-496.5154
-345.36%-125.77
24.79%-72.68
-224.93%-97.82
-232.09%-187.55
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023
Total revenue 120.62B19.11%108B26.79%398.83B19.80%90.68B-43.38%314.56B79.53B-41.56%82.39B-51.73%76.96B-52.66%75.69B-0.80%555.54B
Operating revenue --120.62B19.11%108B26.79%398.83B19.80%90.68B-43.38%314.56B--79.53B-41.56%82.39B-51.73%76.96B-52.66%75.69B-0.80%555.54B
Cost of revenue 55.44B26.22%44.11B21.22%153.44B14.85%34.95B-29.25%126.58B33.39B-29.96%32.87B-36.11%29.89B-33.93%30.43B13.87%178.92B
Gross profit 65.19B14.65%63.89B30.54%245.4B23.14%55.73B-50.09%187.98B46.14B-47.35%49.52B-58.21%47.06B-60.24%45.26B-6.52%376.63B
Operating expense 52.19B-27.16%42.85B-60.27%215.69B-39.24%58.83B19.67%542.82B283.23B-2.59%80.77B-47.49%81.99B-2.40%96.82B32.37%453.6B
Selling and administrative expenses --42.94B-21.39%35.66B-57.95%180.61B-39.43%45.36B15.06%429.54B--237.98B-29.48%57.51B-54.72%59.15B-3.10%74.89B49.88%373.32B
-General and administrative expense --42.94B-21.39%35.66B-57.95%180.61B-39.43%45.36B15.06%429.54B--237.98B-29.48%57.51B-54.72%59.15B-3.10%74.89B49.88%373.32B
Research and development costs --10.35B-37.71%8.18B-55.73%49.87B-52.87%13.12B-14.58%112.64B--38.99B-10.47%23.29B-11.92%22.51B14.01%27.84B38.94%131.86B
Other operating expenses --345M-42.90%366M-56.07%3.57B51.54%641M382.33%8.13B--6.61B51.72%663M20.27%439M49.47%423M53.83%1.69B
Operating profit 13B777.55%21.04B108.37%29.71B93.98%-3.11B-360.95%-354.84B-237.09B-380.54%-31.25B19.75%-34.93B-452.86%-51.57B-227.80%-76.98B
Net non-operating interest income expense -4.88B-141.70%-8.47B-135.26%-11.19B-1.01%20.31B9.24%31.75B19.19B40.57%-17.82B-45.10%9.86B-35.88%20.52B27.86%29.06B
Non-operating interest income --258M-97.38%585M-93.60%2.31B4.78%22.33B11.81%36.02B--20.73B-----43.11%10.71B-35.17%21.32B24.99%32.22B
Non-operating interest expense --5.14B347.06%9.05B215.64%13.5B153.13%2.03B35.39%4.28B--1.54B-40.57%17.82B-1.73%851M-9.40%800M3.57%3.16B
Other net income (expense)
Income before tax 8.74B-30.64%11.93B105.45%17.61B155.40%17.2B-574.28%-323.11B-217.92B-160.40%-49.06B1.96%-25.08B-166.62%-31.05B-157.76%-47.92B
Income tax -80M-42.70%726M26.40%-6.02B-83.78%1.27B-116.77%-8.19B-20.69B161.66%899M-78.61%3.8B-57.83%7.81B15.19%48.79B
Net income 8.82B-29.68%11.21B107.50%23.64B141.01%15.94B-225.63%-314.93B-197.23B-187.41%-49.96B33.37%-28.87B-238.34%-38.86B-338.21%-96.71B
Net income continuous Operations --8.82B-29.68%11.21B107.50%23.64B141.01%15.94B-225.63%-314.93B---197.23B-187.41%-49.96B33.37%-28.87B-238.34%-38.86B-338.21%-96.71B
Minority interest income 00-97.50%1M66.67%-1M100.18%40M31M100.06%4M100.04%2M99.90%-3M-40.40%-22.2B
Net income attributable to the parent company 8.82B-29.69%11.21B107.50%23.63B141.01%15.94B-322.71%-314.97B-197.26B-345.38%-49.97B24.78%-28.88B-224.92%-38.86B-232.08%-74.51B
Preferred stock dividends
Other preferred stock dividends 000000006M0
Net income attributable to common stockholders 8.82B-29.69%11.21B107.50%23.63B141.01%15.94B-322.71%-314.97B-197.26B-345.38%-49.97B24.78%-28.88B-224.94%-38.87B-232.08%-74.51B
Basic earnings per share 22.19-29.67%28.21107.50%59.49141.00%40.11-322.71%-792.79-496.51-345.36%-125.7724.79%-72.68-224.93%-97.82-232.09%-187.55
Diluted earnings per share 22.19-29.67%28.21107.50%59.49141.00%40.11-322.71%-792.79-496.5154-345.36%-125.7724.79%-72.68-224.93%-97.82-232.09%-187.55
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -